Filing Details
- Accession Number:
- 0001437749-16-034509
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-28 12:30:00
- Reporting Period:
- 2016-06-24
- Filing Date:
- 2016-06-28
- Accepted Time:
- 2016-06-28 12:30:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1029125 | Sun Biopharma Inc. | SNBP | Pharmaceutical Preparations (2834) | 870543922 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1133026 | B David Kaysen | 712 Vista Blvd #305 Waconia MN 55387 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-06-24 | 50,000 | $0.00 | 50,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant (right to buy) | Acquisiton | 2016-06-24 | 25,000 | $0.00 | 25,000 | $1.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,000 | 2016-06-24 | 2021-06-24 | No | 4 | P | Direct |
Footnotes
- Reported securities purchased as one share of common stock and one warrant to purchase one-half share of common stock for a combined price of $1.00 per "unit."